These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 8941400
1. Nudicauline and elatine as potent norditerpenoid ligands at rat neuronal alpha-bungarotoxin binding sites: importance of the 2-(methylsuccinimido)benzoyl moiety for neuronal nicotinic acetylcholine receptor binding. Hardick DJ, Blagbrough IS, Cooper G, Potter BV, Critchley T, Wonnacott S. J Med Chem; 1996 Nov 22; 39(24):4860-6. PubMed ID: 8941400 [Abstract] [Full Text] [Related]
2. Conversion of the sodium channel activator aconitine into a potent alpha 7-selective nicotinic ligand. Hardick DJ, Cooper G, Scott-Ward T, Blagbrough IS, Potter BV, Wonnacott S. FEBS Lett; 1995 May 22; 365(1):79-82. PubMed ID: 7774720 [Abstract] [Full Text] [Related]
3. Characterisation of the binding of [3H]methyllycaconitine: a new radioligand for labelling alpha 7-type neuronal nicotinic acetylcholine receptors. Davies AR, Hardick DJ, Blagbrough IS, Potter BV, Wolstenholme AJ, Wonnacott S. Neuropharmacology; 1999 May 22; 38(5):679-90. PubMed ID: 10340305 [Abstract] [Full Text] [Related]
6. Nicotinic pharmacology of anatoxin analogs. II. Side chain structure-activity relationships at neuronal nicotinic ligand binding sites. Wonnacott S, Jackman S, Swanson KL, Rapoport H, Albuquerque EX. J Pharmacol Exp Ther; 1991 Oct 22; 259(1):387-91. PubMed ID: 1920126 [Abstract] [Full Text] [Related]
7. N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slices. Grinevich VP, Crooks PA, Sumithran SP, Haubner AJ, Ayers JT, Dwoskin LP. J Pharmacol Exp Ther; 2003 Sep 22; 306(3):1011-20. PubMed ID: 12766255 [Abstract] [Full Text] [Related]
8. Structure activity studies of ring E analogues of methyllycaconitine. Part 2: Synthesis of antagonists to the alpha3beta4* nicotinic acetylcholine receptors through modifications to the ester. Bergmeier SC, Ismail KA, Arason KM, McKay S, Bryant DL, McKay DB. Bioorg Med Chem Lett; 2004 Jul 16; 14(14):3739-42. PubMed ID: 15203153 [Abstract] [Full Text] [Related]
9. Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor. Jensen AA, Zlotos DP, Liljefors T. J Med Chem; 2007 Sep 20; 50(19):4616-29. PubMed ID: 17722904 [Abstract] [Full Text] [Related]
11. Nicotinic binding sites in rat and mouse brain: comparison of acetylcholine, nicotine, and alpha-bungarotoxin. Marks MJ, Stitzel JA, Romm E, Wehner JM, Collins AC. Mol Pharmacol; 1986 Nov 17; 30(5):427-36. PubMed ID: 3534542 [Abstract] [Full Text] [Related]
12. Pharmacological characterization of [(125)I]CHIBA-1006 binding, a new radioligand for α7 nicotinic acetylcholine receptors, to rat brain membranes. Wu J, Toyohara J, Tanibuchi Y, Fujita Y, Zhang J, Chen H, Matsuo M, Wang RF, Hashimoto K. Brain Res; 2010 Nov 11; 1360():130-7. PubMed ID: 20816767 [Abstract] [Full Text] [Related]
14. [3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity alpha7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain. Anderson DJ, Bunnelle W, Surber B, Du J, Surowy C, Tribollet E, Marguerat A, Bertrand D, Gopalakrishnan M. J Pharmacol Exp Ther; 2008 Jan 11; 324(1):179-87. PubMed ID: 17959745 [Abstract] [Full Text] [Related]
15. Chlorpyrifos, parathion, and their oxons bind to and desensitize a nicotinic acetylcholine receptor: relevance to their toxicities. Katz EJ, Cortes VI, Eldefrawi ME, Eldefrawi AT. Toxicol Appl Pharmacol; 1997 Oct 11; 146(2):227-36. PubMed ID: 9344890 [Abstract] [Full Text] [Related]
16. Synthesis, nicotinic acetylcholine receptor binding, antinociceptive and seizure properties of methyllycaconitine analogs. Ivy Carroll F, Ma W, Navarro HA, Abraham P, Wolckenhauer SA, Damaj MI, Martin BR. Bioorg Med Chem; 2007 Jan 15; 15(2):678-85. PubMed ID: 17098430 [Abstract] [Full Text] [Related]
17. Development of subtype-selective ligands as antagonists at nicotinic receptors mediating nicotine-evoked dopamine release. Crooks PA, Ayers JT, Xu R, Sumithran SP, Grinevich VP, Wilkins LH, Deaciuc AG, Allen DD, Dwoskin LP. Bioorg Med Chem Lett; 2004 Apr 19; 14(8):1869-74. PubMed ID: 15050618 [Abstract] [Full Text] [Related]